Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
midazolam + ketamine + sevoflurane
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral, Intravenous, Intramuscular, Inhalation
01
Overview
This is a combination of three anesthetic/sedative agents used for induction and maintenance of anesthesia or sedation, particularly in pediatric and veterinary settings. Midazolam is a short-acting benzodiazepine providing anxiolysis, amnesia, and sedation; ketamine is an NMDA receptor antagonist providing analgesia and dissociative anesthesia; sevoflurane is an inhaled halogenated ether used for general anesthesia with rapid onset and recovery. The combination leverages the synergistic effects of these drugs to provide balanced anesthesia with reduced side effects compared to single-agent use[2][6][8].
- Other names
- midazolam, ketamine and sevofluranemidazolam/ketamine/sevoflurane
02
Targets
NMDAR (Glutamate receptor ionotropic, NMDA)GLRA1 (Glycine receptor subunit Alpha-1)
Beyond the preview
Go deeper on midazolam + ketamine + sevoflurane.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on midazolam + ketamine + sevoflurane.